Selected article for: "acute illness and long syndrome"

Author: Kersten, Johannes; Baumhardt, Michael; Hartveg, Paul; Hoyo, Luis; Hüll, Elina; Imhof, Armin; Kropf-Sanchen, Cornelia; Nita, Nicoleta; Mörike, Johannes; Rattka, Manuel; Andreß, Stefanie; Scharnbeck, Dominik; Schmidtke-Schrezenmeier, Gerlinde; Tadic, Marijana; Wolf, Alexander; Rottbauer, Wolfgang; Buckert, Dominik
Title: Long COVID: Distinction between Organ Damage and Deconditioning
  • Cord-id: v4orktce
  • Document date: 2021_8_24
  • ID: v4orktce
    Snippet: (1) Background: Long COVID syndrome refers to long-term sequelae of the novel viral disease, which occur even in patients with initially mild disease courses. However, there is still little evidence of the actual organic consequences and their frequency, and there is no standardized workup to diagnose long COVID syndrome yet. In this study, we aim to determine the efficiency of a stepwise diagnostic approach for reconvalescent COVID-19 patients with cardiopulmonary symptoms. (2) Methods: The dia
    Document: (1) Background: Long COVID syndrome refers to long-term sequelae of the novel viral disease, which occur even in patients with initially mild disease courses. However, there is still little evidence of the actual organic consequences and their frequency, and there is no standardized workup to diagnose long COVID syndrome yet. In this study, we aim to determine the efficiency of a stepwise diagnostic approach for reconvalescent COVID-19 patients with cardiopulmonary symptoms. (2) Methods: The diagnostic workup for long COVID syndrome included three steps. In the first step, the focus was on broad applicability (e.g., blood tests and body plethysmography). In the second step, cardiopulmonary exercise testing (CPET) and cardiac MRI (CMR) were used. The third step was tailored to the individual needs of each patient. The observation period lasted from 22 February to 14 May 2021. (3) Results: We examined 231 patients in our long COVID unit (mean [SD] age, 47.8 [14.9], 132 [57.1%] women). Acute illness occurred a mean (SD) of 121 (77) days previously. Suspicious findings in the first visit were seen in 80 (34.6%) patients, prompting further diagnostics. Thirty-six patients were further examined with CPET and CMR. Of those, 16 (44.4%) had pathological findings. The rest had functional complaints without organ damage (“functional long COVID”). Cardiopulmonary sequelae were found in asymptomatic as well as severe courses of the initial COVID-19 disease. (4) Conclusions: A structured diagnostic pathway for the diagnosis of long COVID syndrome is practicable and rational in terms of resource allocation. With this approach, manifest organ damage can be accurately and comprehensively diagnosed and distinguished from functional complaints.

    Search related documents:
    Co phrase search for related documents
    • abnormal finding and acute illness: 1, 2
    • abnormal finding and long covid: 1, 2, 3, 4
    • absence presence and actual prevalence: 1
    • absence presence and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • absence presence and acute illness: 1, 2, 3, 4, 5, 6
    • absence presence and long covid: 1, 2, 3, 4, 5, 6
    • actual prevalence and acute disease: 1
    • actual prevalence and long covid: 1
    • acute disease and local availability: 1
    • acute disease and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and long covid patient: 1, 2, 3, 4, 5
    • acute disease and long covid prevalence: 1, 2, 3
    • acute disease and long covid symptom: 1
    • acute illness and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute illness and long covid symptom: 1
    • local availability and long covid: 1, 2